Belgium to fight cancer with radioligand therapy boom by 2027

EURACTIV - Belgium expects demand for radioligand therapy (RLT) to double by 2027, introducing key reforms to ensure patients can access these targeted cancer treatments on time. Read more

Flemish Minister-President Matthias Diependaele, visiting the nuclear medicine department at the University Hospital of Antwerp. [Photo: Benjamin Brolet]